Association between the 110‐kDa C‐terminal agrin fragment and skeletal muscle decline among community‐dwelling older women
暂无分享,去创建一个
K. Kouda | M. Iki | J. Tamaki | Yuho Sato | T. Tachiki | E. Kajita | S. Kagamimori | K. Kamiya
[1] J. Conroy,et al. Plasma C-Terminal Agrin Fragment as an Early Biomarker for Sarcopenia: Results From the GenoFit Study , 2021, The journals of gerontology. Series A, Biological sciences and medical sciences.
[2] M. Narici,et al. Neuromuscular junction instability and altered intracellular calcium handling as early determinants of force loss during unloading in humans , 2021, The Journal of physiology.
[3] Yan Zhang,et al. Sarcopenia in heart failure: a systematic review and meta‐analysis , 2021, ESC heart failure.
[4] M. Narici,et al. Neuromuscular Junction Aging: A Role for Biomarkers and Exercise. , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.
[5] D. Goulis,et al. Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis , 2020, Calcified Tissue International.
[6] L. Peng,et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. , 2020, Journal of the American Medical Directors Association.
[7] A. Cruz-Jentoft,et al. Biomarkers of sarcopenia in very old patients with hip fracture , 2020, Journal of cachexia, sarcopenia and muscle.
[8] D. Jones,et al. Five-year longitudinal changes in thigh muscle mass of septuagenarian men and women assessed with DXA and MRI , 2019, Aging Clinical and Experimental Research.
[9] René Rizzoli,et al. Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.
[10] Yuan-Fang Li,et al. The Reference Intervals for Serum C‐Terminal Agrin Fragment in Healthy Individuals and as a Biomarker for Renal Function in Kidney Transplant Recipients , 2017, Journal of clinical laboratory analysis.
[11] P. Abete,et al. Biomarkers in sarcopenia: A multifactorial approach , 2016, Experimental Gerontology.
[12] T. Malmstrom,et al. Frailty and Sarcopenia as Predictors of Adverse Health Outcomes in Persons With Diabetes Mellitus. , 2016, Journal of the American Medical Directors Association.
[13] G. Onder,et al. Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older multimorbid community-dwellers: Results from the ilSIRENTE study , 2016, Experimental Gerontology.
[14] F. Raymond,et al. A robust neuromuscular system protects rat and human skeletal muscle from sarcopenia , 2016, Aging.
[15] C. Wagner,et al. C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics , 2015, PloS one.
[16] S. Anker,et al. Detection of muscle wasting in patients with chronic heart failure using C‐terminal agrin fragment: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF) , 2015, European journal of heart failure.
[17] M. Iki,et al. Cohort Profile Cohort Profile : The Japanese Population-based Osteoporosis ( JPOS ) Cohort Study , 2015 .
[18] D. Jones,et al. Comparison of MRI and DXA to measure muscle size and age-related atrophy in thigh muscles. , 2013, Journal of musculoskeletal & neuronal interactions.
[19] R. Nagatomi,et al. An inverted J-shaped association of serum uric acid with muscle strength among Japanese adult men: a cross-sectional study , 2013, BMC Musculoskeletal Disorders.
[20] S. Anker,et al. C-terminal agrin-fragment as a novel diagnostic marker for muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure , 2013 .
[21] M. Bolliger,et al. Zymogen activation of neurotrypsin and neurotrypsin-dependent agrin cleavage on the cell surface are enhanced by glycosaminoglycans. , 2013, The Biochemical journal.
[22] P. Kwan. Sarcopenia, a Neurogenic Syndrome? , 2013, Journal of aging research.
[23] W. Uter,et al. C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction , 2013, Experimental Gerontology.
[24] P. Dahinden,et al. Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients , 2013, Experimental Gerontology.
[25] M. Bolliger,et al. Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] M. Francolini,et al. Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction , 2010, Journal of Cell Science.
[27] K. Shigemoto,et al. Muscle weakness and neuromuscular junctions in aging and disease , 2010, Geriatrics & gerontology international.
[28] M. Deschenes,et al. Remodeling of the neuromuscular junction precedes sarcopenia related alterations in myofibers , 2010, Experimental Gerontology.
[29] M. Kjaer,et al. Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure , 2010, Scandinavian journal of medicine & science in sports.
[30] Yasuhiko Tomino,et al. Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[31] P. Sonderegger,et al. Neurotrypsin cleaves agrin locally at the synapse , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] Kazutoshi Nakamura,et al. Development of a simple food frequency questionnaire to estimate intakes of calcium and other nutrients for the prevention and management of osteoporosis. , 2008, Journal of nutritional science and vitaminology.
[33] T. Lømo,et al. Neural agrin controls acetylcholine receptor stability in skeletal muscle fibers , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Ruegg,et al. Acetylcholine receptor-aggregating activity of agrin isoforms and mapping of the active site , 1995, The Journal of cell biology.
[35] Y. Fujita,et al. Muscle strength is associated with bone health independently of muscle mass in postmenopausal women: the Japanese population-based osteoporosis study , 2017, Journal of Bone and Mineral Metabolism.
[36] M A Laskey,et al. Dual-energy X-ray absorptiometry and body composition. , 1996, Nutrition.
[37] Human Experimentation: Code of Ethics of the World Medical Association (Declaration of Helsinki). , 1964, Canadian Medical Association journal.